Adenocarcinoma gastric – Life with Disease

Go back

Adenocarcinoma gastric, also known as stomach cancer, develops in the cells that line the innermost layer of the stomach and represents the most common form of gastric malignancy worldwide. This condition often progresses quietly in its early stages, making understanding its full impact on life and treatment options essential for patients and their families.

Understanding the Prognosis of Gastric Adenocarcinoma

The outlook for someone diagnosed with gastric adenocarcinoma depends greatly on when the disease is discovered and how far it has spread. When doctors talk about prognosis, they’re discussing what might happen over time with the disease and the chances of recovery or long-term survival. This conversation can be difficult, but understanding the reality helps patients and families prepare and make informed decisions about care.[1]

When gastric adenocarcinoma is found early, before it has spread beyond the stomach, more than half of patients can achieve cure, particularly with localized distal gastric cancer. Unfortunately, early-stage disease accounts for only about 10% to 20% of all cases diagnosed in the United States. Most people are diagnosed after the cancer has already spread to regional lymph nodes or distant sites in the body.[14]

The survival outlook changes significantly based on the stage at diagnosis. For patients with cancer that has metastasized, meaning it has spread to distant organs like the liver or lungs, the five-year survival rate drops to approximately 5%. In contrast, patients with localized disease confined to resectable regional areas may have survival rates approaching 50%. The prognosis is also influenced by factors such as how deep the tumor has grown into the stomach wall, whether lymph nodes are involved, and the grade of the tumor cells.[1][14]

For patients receiving conventional chemotherapy for metastatic gastric cancer, the median overall survival is around 12 months. However, recent therapeutic advances, including immunotherapy and targeted therapies, have shown promise in extending survival for certain patients, particularly those whose tumors have specific biomarkers like microsatellite instability (a condition where DNA repair mechanisms don’t work properly), PD-L1 expression (a protein marker), or HER2 positivity (a growth factor receptor).[9][13]

⚠️ Important
Statistical survival rates are averages based on large groups of patients and cannot predict what will happen to any individual person. Your own outcome depends on many personal factors, including your overall health, the specific characteristics of your cancer, how your body responds to treatment, and advances in medical care that may not be reflected in older statistics.

How Gastric Adenocarcinoma Progresses Without Treatment

Gastric adenocarcinoma develops slowly over many years, typically starting with small changes in the DNA (the genetic instruction manual) of stomach cells. These mutations cause cells to multiply uncontrollably instead of dying when they should, eventually forming abnormal growths called tumors.[1]

The cancer begins in the mucosa, which is the innermost lining of the stomach where gland cells produce mucus and digestive juices. At this very early stage, known as carcinoma in situ or stage 0, the abnormal cells haven’t yet broken through to deeper layers. If left untreated, these cells continue to grow and invade deeper into the stomach wall, passing through multiple layers including the submucosa (tissue beneath the lining), the muscle layers, and eventually the outer covering of the stomach.[3][4]

As the tumor grows, it can spread to nearby lymph nodes. Lymph nodes are small, bean-shaped structures that are part of the immune system and help filter harmful substances. Once cancer cells reach these nodes, they can travel through the lymphatic system to more distant parts of the body. This process is called lymphatic spread, and it represents a significant step in the disease’s progression.[5]

Eventually, without intervention, gastric adenocarcinoma can spread beyond the stomach to nearby organs such as the liver, pancreas, or esophagus. It can also travel through the bloodstream to reach distant sites like the lungs, bones, or brain. When cancer spreads to organs far from where it started, this is called metastasis. At this advanced stage, the cancer becomes much more difficult to treat and significantly impacts survival.[6]

The speed at which gastric adenocarcinoma progresses varies. Some types, like diffuse adenocarcinomas, which are poorly differentiated and don’t resemble normal stomach cells under a microscope, tend to grow and spread more quickly than intestinal types. A rare and aggressive form called linitis plastica causes the stomach walls to become thick and rigid, often reaching advanced stages by the time it’s diagnosed.[4][7]

Possible Complications of Gastric Adenocarcinoma

Gastric adenocarcinoma can lead to various complications that worsen quality of life and create additional medical challenges. Understanding these potential complications helps patients and caregivers prepare for what might arise during the disease course.

One common complication is obstruction, where the tumor grows large enough to block the passage of food either into or out of the stomach. When the cancer blocks the connection between the esophagus and stomach, patients experience severe difficulty swallowing. When it blocks the exit from the stomach into the small intestine, food cannot move forward properly, causing persistent vomiting, severe nausea, and dangerous weight loss.[11]

Bleeding is another serious complication. The tumor can erode through blood vessels in the stomach wall, causing bleeding that may be slow and chronic or sudden and severe. Patients might notice blood in their vomit, which can appear bright red or look like coffee grounds. They may also see dark, tarry stools, which indicate digested blood passing through the digestive system. Chronic bleeding leads to anemia, a condition where the body doesn’t have enough healthy red blood cells to carry oxygen, resulting in profound fatigue and weakness.[3][17]

Perforation, though less common, is a life-threatening complication where the tumor creates a hole through the stomach wall. This allows stomach contents to leak into the abdominal cavity, causing severe infection called peritonitis. Perforation requires emergency surgery and can be fatal if not treated immediately.[5]

Nutritional complications are extremely common in gastric adenocarcinoma. Up to 80% of people with advanced stomach cancer become malnourished. The tumor itself can interfere with the stomach’s ability to process food. Additionally, the cancer may cause loss of appetite, early feelings of fullness, and changes in how food tastes or smells. These factors combine to make it very difficult for patients to consume enough calories and protein to maintain their weight and strength.[3][24]

When gastric adenocarcinoma spreads to the liver, it can cause jaundice, a yellowing of the skin and eyes. This happens when the liver cannot properly process a substance called bilirubin. Liver metastases can also cause abdominal pain, swelling, and liver failure in advanced cases.[3]

Fluid accumulation in the abdomen, called ascites, can occur when cancer spreads to the lining of the abdominal cavity or when the liver is affected. This causes uncomfortable swelling and pressure, difficulty breathing, and changes in appetite. The fluid may need to be drained periodically to provide relief.[5]

Impact on Daily Life and Activities

Living with gastric adenocarcinoma affects nearly every aspect of daily life, from physical abilities to emotional wellbeing to social relationships. The disease and its treatments create challenges that require significant adjustments and support.

Physically, many patients experience profound fatigue that goes beyond normal tiredness. This cancer-related fatigue doesn’t improve much with rest and can make even simple tasks feel overwhelming. Daily activities like showering, dressing, preparing meals, or walking short distances may become exhausting. This fatigue results from multiple factors including the cancer itself, treatment side effects, poor nutrition, anemia, and the emotional stress of dealing with a serious illness.[19][20]

The relationship with food changes dramatically for people with gastric adenocarcinoma. Eating, which was once a source of pleasure and social connection, often becomes a source of anxiety and discomfort. Many patients lose their appetite completely or feel full after just a few bites. Foods that were once favorites may taste strange or unappealing. Some patients experience nausea at the sight or smell of food. These changes can be isolating, especially during social gatherings centered around meals.[22][24]

After surgery to remove part or all of the stomach, eating requires significant modifications. Patients need to eat smaller, more frequent meals throughout the day rather than three standard meals. They may need to avoid certain foods that cause discomfort or symptoms like dumping syndrome, where food moves too quickly from the stomach into the small intestine, causing nausea, cramping, diarrhea, dizziness, and rapid heartbeat. These dietary restrictions can make social eating difficult and may lead to feelings of isolation or being different from others.[22][26]

Work life is often significantly affected. During active treatment, frequent medical appointments every two weeks for chemotherapy, plus additional visits for monitoring and managing side effects, can make maintaining regular employment very challenging. The physical side effects of treatment, including fatigue, nausea, and decreased strength, may prevent patients from performing their job duties. Many people need to reduce their work hours, take extended leave, or stop working entirely during treatment.[9][23]

Hobbies and recreational activities may need to be modified or temporarily abandoned. Physical activities like sports, gardening, or exercise may be too demanding during treatment. Even less physically demanding hobbies may feel overwhelming when energy is limited. This loss of enjoyable activities can contribute to feelings of depression and loss of identity.

Emotionally, a diagnosis of gastric adenocarcinoma can trigger anxiety, fear, sadness, and uncertainty about the future. Worrying about treatment outcomes, disease progression, financial concerns, and how the illness affects loved ones is common and normal. Some patients experience depression, which is more than temporary sadness and may require professional support. The fear of cancer returning or progressing can persist even after successful treatment.[19][20]

Body image changes can be significant, particularly after surgery that removes part or all of the stomach. Weight loss, surgical scars, and changes in how the body looks can affect self-esteem and comfort in intimate relationships. Some patients experience changes in their sexual health and relationships due to physical changes, fatigue, or emotional concerns.[6][23]

⚠️ Important
Speaking openly with your healthcare team about how the disease and treatment affect your daily life is essential. Many challenges can be addressed with supportive care, including working with dietitians for nutrition concerns, counseling for emotional support, physical therapy for fatigue and strength, and medications to manage symptoms. You don’t have to cope with these difficulties alone.

Social relationships may change as well. Some friends and family members may not know how to offer support or may feel uncomfortable discussing the illness. Others may become overprotective or treat the patient differently. Maintaining social connections requires effort from both patients and their support network, and honest communication about needs and boundaries helps preserve important relationships.

Financial stress adds another layer of difficulty. Even with insurance, patients face costs for copayments, medications, parking and transportation to appointments, special foods or nutritional supplements, and home modifications. Lost income from reduced work hours compounds these expenses. This financial burden, sometimes called financial toxicity, can cause significant stress and anxiety.[19][20]

Coping with these challenges requires a combination of practical strategies and emotional support. Working with a dietitian can help maximize nutrition even when appetite is poor. Eating high-calorie, high-protein foods in small amounts throughout the day, keeping convenient snacks available, and using liquid nutritional supplements when solid food is unappealing can help maintain strength. Pacing activities and prioritizing what’s most important helps conserve energy. Accepting help from others with household tasks, transportation, or meal preparation allows patients to focus energy on treatment and recovery.[22][24]

Mental health support through counseling, support groups, or talking with others who have faced similar challenges can provide emotional relief and practical coping strategies. Many cancer centers offer psychosocial oncology services that address the emotional and practical aspects of living with cancer. Some patients find benefit in practices like meditation, gentle exercise when possible, journaling, or spending time in nature.[20]

Support for Families: Understanding Clinical Trials

For families of people with gastric adenocarcinoma, understanding clinical trials can be important when exploring all available treatment options. Clinical trials are research studies that test new approaches to treating, preventing, or detecting cancer. They play a crucial role in advancing medical knowledge and may offer access to promising new treatments before they become widely available.[11]

Families should understand that participating in a clinical trial is always voluntary. Clinical trials for gastric adenocarcinoma may test new chemotherapy drugs, immunotherapy approaches, targeted therapies, combinations of existing treatments, or new surgical techniques. Some trials compare a new treatment against the current standard of care to see if the new approach works better. Others study quality of life, symptom management, or ways to reduce treatment side effects.[13][16]

The decision to participate in a clinical trial involves understanding potential benefits and risks. Potential benefits include access to new treatments that might work better than current options, close monitoring by the medical team, and contributing to research that may help future patients. However, new treatments may have unknown or unexpected side effects, may not work as well as hoped, and may require additional visits or tests beyond standard care.[10]

Families can help their loved ones explore clinical trial options by asking the oncologist about trials that might be appropriate based on the specific stage and characteristics of the cancer. The doctor can explain which trials the patient might be eligible for and discuss the potential risks and benefits in their particular situation. Many cancer centers have clinical trial coordinators who can provide detailed information about available studies.[11]

When considering a clinical trial, important questions families can help their loved one ask include: What is the purpose of this trial? What phase is the trial in? What treatments are involved? What are the possible benefits and risks? How does this compare to standard treatment? What costs are covered by the trial and what might the patient need to pay? How often are visits required and where? How long does the trial last? What happens when the trial ends?[10]

Families can assist with clinical trial participation in practical ways. They can help research trial options online through resources like the National Cancer Institute’s clinical trials database or the cancer center’s trial listings. They can accompany the patient to appointments to help listen and remember information, take notes during discussions, and ask questions. They can help organize the paperwork and consent forms that are part of trial participation.[11]

Transportation to and from trial-related appointments, which may be frequent, is another way families provide valuable support. They can help track symptoms or side effects that need to be reported to the research team and assist with any additional tests or monitoring required by the trial protocol.

It’s important for families to know that patients can leave a clinical trial at any time for any reason. If side effects become too difficult, if the treatment isn’t working, or if the patient simply decides they no longer want to participate, they have the right to withdraw. Leaving a trial doesn’t mean losing access to their medical team or standard treatment options.[10]

Families should also understand that not every patient is eligible for every trial. Trials have specific criteria about cancer stage, previous treatments, overall health status, and other factors. Just because a patient isn’t eligible for one trial doesn’t mean other options aren’t available. The medical team can help navigate these options and find the best fit for each individual situation.

Supporting a loved one through clinical trial participation involves helping them weigh the potential benefits against the risks, respecting their autonomy in making the decision, and providing practical and emotional support throughout the process. Having family members who understand the trial details and can advocate for the patient’s needs helps ensure the best possible experience and outcomes.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Trastuzumab (Herceptin®) – A monoclonal antibody that targets the HER2 pathway, approved for subsets of patients with advanced, HER2-positive gastroesophageal cancer
  • Ramucirumab (Cyramza®) – A monoclonal antibody that targets the VEGF/VEGFR2 pathway and inhibits tumor blood vessel growth, approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Trastuzumab deruxtecan (Enhertu®) – An antibody-drug conjugate that targets the HER2 pathway, approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Pembrolizumab (Keytruda®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Nivolumab (Opdivo®) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced stomach or gastroesophageal cancer
  • Dostarlimab (Jemperli) – A checkpoint inhibitor that targets the PD-1/PD-L1 pathway, approved for subsets of patients with advanced stomach or gastroesophageal cancer that has DNA mismatch repair deficiency (dMMR)

Ongoing Clinical Trials on Adenocarcinoma gastric

  • A study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Czechia France Italy Poland Spain
  • Study of intraperitoneal chemotherapy (PIPAC) with cisplatin and doxorubicin combined with minimally invasive surgery in patients with high-risk gastric cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Denmark France Sweden
  • Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Study of JK06 for Patients with Advanced or Metastatic Cancer

    Recruiting

    1 1
    Investigated drugs:
    Belgium Spain
  • Study on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Spain
  • Study on the Effectiveness of Oxaliplatin, Docetaxel, and Fluorouracil in Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Recruiting

    1 1 1 1
    Germany
  • Study on the Effectiveness of Bemarituzumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Italy Poland Spain
  • Study of Zolbetuximab and CAPOX for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Portugal Romania Spain
  • Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

    Not recruiting

    1 1 1 1
    Austria Germany Italy

References

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/symptoms-causes/syc-20352438

https://www.cancer.org/cancer/types/stomach-cancer/about/what-is-stomach-cancer.html

https://www.medicalnewstoday.com/articles/adenocarcinoma-stomach-cancer

https://www.cancer.gov/types/stomach

https://pmc.ncbi.nlm.nih.gov/articles/PMC1356843/

https://my.clevelandclinic.org/health/diseases/21652-adenocarcinoma-cancers

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/types-and-grades

https://www.mskcc.org/cancer-care/types/stomach-gastric

https://pmc.ncbi.nlm.nih.gov/articles/PMC10502549/

https://www.mayoclinic.org/diseases-conditions/stomach-cancer/diagnosis-treatment/drc-20352443

https://www.cancer.gov/types/stomach/treatment

https://www.cancer.org/cancer/types/stomach-cancer/treating/by-stage.html

https://jhoonline.biomedcentral.com/articles/10.1186/s13045-023-01451-3

https://www.cancer.gov/types/stomach/hp/stomach-treatment-pdq

https://pmc.ncbi.nlm.nih.gov/articles/PMC9927927/

https://www.cancerresearch.org/immunotherapy-by-cancer-type/stomach-cancer

https://my.clevelandclinic.org/health/diseases/15812-stomach-cancer

https://jgo.amegroups.org/article/view/77640/html

https://www.cancer.gov/types/stomach/coping

https://www.cancercare.org/publications/224-coping_with_gastric_cancer

https://www.cancer.org/cancer/types/stomach-cancer/after-treatment/follow-up.html

https://cancer.ca/en/cancer-information/cancer-types/stomach/supportive-care/nutrition-and-stomach-cancer

https://health.clevelandclinic.org/coping-with-stomach-cancer-changes

https://www.healthline.com/health/cancer/diet-and-nutrition-for-stomach-cancer

https://www.mskcc.org/cancer-care/types/stomach-gastric/treatment

https://www.cancerresearchuk.org/about-cancer/stomach-cancer/living-with/eating-problems

FAQ

Can gastric adenocarcinoma be cured?

Yes, gastric adenocarcinoma can be cured if detected at an early stage before it spreads beyond the stomach. More than 50% of patients with localized distal gastric cancer can be cured through surgery, sometimes combined with chemotherapy. However, cure is rarely achieved when the cancer has spread to distant organs. The key to cure is early detection, which is why any persistent stomach symptoms should be evaluated by a doctor.

Why don’t I have symptoms even though I have stomach cancer?

Early-stage gastric adenocarcinoma typically doesn’t cause noticeable symptoms because the tumor is still small and hasn’t significantly affected stomach function. Symptoms usually only appear as the cancer grows larger or spreads. This is why stomach cancer is often diagnosed at more advanced stages in countries without routine screening programs. Common symptoms when they do occur include unexplained weight loss, stomach pain, feeling full quickly, and digestive problems.

Will I be able to eat normally after stomach surgery?

After partial or complete removal of the stomach (gastrectomy), your eating habits will need to change, but many people adapt successfully over time. You’ll need to eat smaller, more frequent meals throughout the day rather than three large meals. Some foods may need to be avoided to prevent dumping syndrome, where food moves too quickly through your digestive system. Working with a dietitian helps you learn which foods work best for your body and how to get adequate nutrition despite these changes.

Is stomach cancer hereditary?

Yes, stomach cancer can have a hereditary component. Sometimes people inherit DNA mutations that increase their risk of developing gastric cancer. Warning signs of hereditary stomach cancer include being diagnosed at a younger age, having a history of multiple cancers, or having several family members with cancer. If you have a family history of stomach cancer, especially in first-degree relatives, it’s important to discuss this with your doctor, as you may benefit from earlier or more frequent screening.

What is dumping syndrome and how is it managed?

Dumping syndrome is a group of symptoms that can occur after stomach surgery when food moves too quickly from the stomach into the small intestine. Early dumping happens shortly after eating and causes nausea, diarrhea, cramping, dizziness, and rapid heartbeat. Late dumping occurs 1-3 hours after eating due to blood sugar changes. Managing dumping syndrome involves eating smaller meals more frequently, reducing sugary foods, increasing protein and fat intake, adding more fiber, avoiding liquids with meals, and eating slowly while resting after meals.

🎯 Key takeaways

  • Gastric adenocarcinoma accounts for 90-95% of all stomach cancers and develops slowly over many years in the stomach’s innermost lining
  • Early detection dramatically improves outcomes, with cure possible in over 50% of localized cases, but most U.S. patients are diagnosed at advanced stages when symptoms finally appear
  • H. pylori bacterial infections cause nearly half of all stomach cancers and represent a major preventable risk factor
  • Treatment often involves multiple approaches including surgery, chemotherapy, targeted therapy, and immunotherapy, requiring frequent medical appointments every two weeks during active treatment
  • Up to 80% of people with advanced gastric cancer become malnourished, making nutritional support with dietitian guidance essential throughout treatment
  • After stomach removal surgery, eating habits change permanently—patients need smaller, more frequent meals and may experience dumping syndrome requiring dietary modifications
  • Biomarkers like HER2, PD-L1, and microsatellite instability now guide personalized treatment decisions, with immunotherapy showing particular promise in certain patient subgroups
  • The disease significantly impacts daily life including work, social activities, relationships with food, and emotional wellbeing, requiring comprehensive support beyond medical treatment alone